Assessing the clinical utility of cancer genomic and proteomic data across tumor types.
...
Published in Nature biotechnology
Molecular profiling of tumors promises to advance the clinical management of cancer, but the benefits of integrating molecular data with traditional clinical variables have not been systematically studied. Here we retrospectively predict patient survival using diverse molecular data (somatic copy-number alteration, DNA methylation and mRNA, microRN...
